Clinical Trial

¹²⁹Xe(XENON) MRI Program

Name: ¹²⁹Xe(XENON) MRI Program — clinical trial record (NCT07533981)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Healthy volunteers aged 18 to 85 will undergo hyperpolarized Xenon-129 (¹²⁹Xe) MRI and pulmonary function testing. The study aims to develop evaluation tools for ventilation defect percent (VDP), signal-to-noise and contrast-to-noise ratios (SNR/CNR) of ¹²⁹Xe dissolved-phase images, and spectroscopy-based analysis.

Trial Details

NCT Number	NCT07533981
Lead Sponsor	Alexei Ouriadov Collaborators: St. Joseph's Health Care London
Conditions	Healthy Volunteers - Male and Female
Enrollment	200 participants
Start Date	2026-07-01
Primary Completion	2030-12-30 (estimated)
Study Completion	2031-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-16